Literature DB >> 2647324

Bloom's syndrome. XII. Report from the Registry for 1987.

J German1, E Passarge.   

Abstract

Bloom's syndrome has been known as a clinical entity for 34 years. Careful records of cases diagnosed throughout the world have been maintained since its recognition as an entity, and most instances of cytologically verified Bloom's syndrome have been accessioned to what has been referred to as the Bloom's Syndrome Registry since the mid-1960s. Presented here is the fourth in a series of progress reports from the Registry of information accumulated during this long-term surveillance of affected families, along with mention of selected recent advances that have been made in the understanding of the syndrome. 130 persons had been accessioned to the Registry by the end of 1987; 96 of these were alive, their mean age being 18.9 years. Although a number of clinical complications occur in Bloom's syndrome, the most important is malignant neoplasia. In the 130 persons in the Registry, 57 malignant neoplasms had been detected, the mean age at diagnosis being 24.8 years. Neoplasia in Bloom's syndrome is noteworthy not only because of its frequency and exceptionally early age of emergence but for its variety of histological types and sites of origin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647324     DOI: 10.1111/j.1399-0004.1989.tb02905.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  20 in total

1.  Increased expression of 5q31 fragile site in a Bloom syndrome family.

Authors:  A F Fundia; N B Gorla; M M Bonduel; O Azpilicueta; H Lejarraga; F S Muriel; I B Larripa
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

2.  Elevated sister chromatid exchange phenotype of Bloom syndrome cells is complemented by human chromosome 15.

Authors:  L D McDaniel; R A Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.

Authors:  R G Langlois; W L Bigbee; R H Jensen; J German
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  A conditional mouse model for measuring the frequency of homologous recombination events in vivo in the absence of essential genes.

Authors:  Adam D Brown; Alison B Claybon; Alexander J R Bishop
Journal:  Mol Cell Biol       Date:  2011-06-27       Impact factor: 4.272

5.  Association study of leukocyte telomere length and genetic polymorphism within hTERT promoter with type 2 diabetes in Bangladeshi population.

Authors:  Atoll Goswami; Nafiul Huda; Tahirah Yasmin; Md Ismail Hosen; A K M Mahbub Hasan; A H M Nurun Nabi
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

Review 6.  DNA damage response and hematological malignancy.

Authors:  Masatoshi Takagi
Journal:  Int J Hematol       Date:  2017-04-03       Impact factor: 2.490

7.  The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry.

Authors:  N A Ellis; S Ciocci; M Proytcheva; D Lennon; J Groden; J German
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

8.  Chromosomal breakage in human spermatozoa, a heterozygous effect of the Bloom syndrome mutation.

Authors:  R H Martin; A Rademaker; J German
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  Bloom syndrome: an analysis of consanguineous families assigns the locus mutated to chromosome band 15q26.1.

Authors:  J German; A M Roe; M F Leppert; N A Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Non-Bloom syndrome-associated partial and total loss-of-function variants of BLM helicase.

Authors:  Hamed Mirzaei; Kristina H Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.